The application discloses a recombination preparation method of C-
peptide modified
insulin analog, and belongs to the technical field of
biopharmaceutical genetic engineering. The application optimizes the connection structure of C-
peptide, A chain and B chain by site-directed
mutation to modify the
amino acid sequence of
insulin C-
peptide, constructs a recombination
expression vector, realizes high-efficiency soluble expression by using an E. coli
prokaryotic expression system, and obtains an
insulin analog with high stability, long half-life and low
immunogenicity through enzymatic
cutting, purification, refolding, modification and refining. The application solves the problems of low folding efficiency and low product purity of traditional recombination insulin by modifying the hydrophilicity and spatial conformation of C-peptide. Meanwhile, the modified C-peptide can
delay the dissociation speed of insulin in the body, prolong the
drug action time and stably control blood glucose. The preparation process of the application is simple, the yield is high, the cost is low, the product has stable
biological activity, is suitable for large-scale industrial production, and has extremely high application value in the field of long-acting hypoglycemic
drug preparation for diabetes.